Literature DB >> 4065193

Effects of a stable prostaglandin analogue, L-644,122, in healthy and hypertensive men.

J M Ritter, J R Ludgin, L A Scharschmidt, R D Smith, M J Dunn.   

Abstract

L-644,122 is a chemically stable vasodilator prostaglandin analogue. It is a selective renal vasodilator in dogs. The object of the present study was to determine whether it increases effective renal plasma flow (ERPF) in man. L-644,122 was administered intravenously to 4 healthy volunteers and by mouth to 4 mild hypertensives. It did not increase ERPF. Instead it acted as a non-specific vasodilator, lowering diastolic blood pressure and increasing heart rate. An unexpected increase in glomerular filtration rate (19% greater than placebo) after low dose intravenous L-644,122 merits further study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065193     DOI: 10.1007/BF00607916

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Observations on the effects of infusion of prostaglandin E in man.

Authors:  S BERGSTROM; H DUNER; U von EULER; B PERNOW; J SJOVALL
Journal:  Acta Physiol Scand       Date:  1959-03-31

2.  A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow.

Authors:  D P EARLE; R W BERLINER
Journal:  Proc Soc Exp Biol Med       Date:  1946-06

3.  Renal and cardiovascular effect of prostaglandin A2 in hypertensive patients.

Authors:  A Hornych; M Safar; N Papanicolaou; P Meyer; P Milliez
Journal:  Eur J Clin Invest       Date:  1973-09       Impact factor: 4.686

4.  Prostaglandin A1: antihypertensive and renal effects. Studies in patients with essential hypertension.

Authors:  J B Lee; J C McGiff; H Kannegiesser; Y Y Aykent; J G Mudd; T F Frawley
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

5.  An orally active prostaglandin analog with renal vasodilatory activity in the dog.

Authors:  E H Blaine; H F Russo; T W Schorn; C Snyder
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

6.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

7.  Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilators.

Authors:  J B Bicking; M G Bock; E J Cragoe; R M DiPardo; N P Gould; W J Holtz; T J Lee; C M Robb; R L Smith; J P Springer; E H Blaine
Journal:  J Med Chem       Date:  1983-03       Impact factor: 7.446

8.  Reversal of indomethacin-induced decreases in renal function by an isosterically-modified prostaglandin analog.

Authors:  E H Blaine
Journal:  Prostaglandins       Date:  1983-11

9.  Renal vasodilation by a prostaglandin analog during dopaminergic and alpha-adrenergic blockade.

Authors:  A A Seymour; E H Blaine
Journal:  Prostaglandins Leukot Med       Date:  1983-03

10.  Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).

Authors:  M A Orchard; J M Ritter; G L Shepherd; P J Lewis
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.